Research location
Meaux
France
Advertisement
Research activity in Meaux
FranceCureCurrent currently publishes aggregate city-level research activity for this location: 65 trials and 67 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Meaux
65 linked trials · page 1 of 2The Real-World Control-IQ Glycemic Control and Quality of Life Study in Type 1 Diabetes in FranceNCT07211126 · 2026-03-03 · 1 site observation
RECRUITING
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular DiseaseNCT07064473 · 2025-07-22 · 1 site observation
RECRUITING
Long-Terms Responders in Metastatic Lung Cancer: Better Understanding for Better Management (Lungevity Study)NCT07243132 · 2025-07-02 · 1 site observation
RECRUITING
UmbREALung - A Retrospective and Prospective, Observational, Real World Multi-cohort Study of Patients With Non-small Cell Lung Cancer (NSCLC) Initiating Approved Drugs Developed by AZ or as Part of an AZ AllianceNCT06726720 · 2024-12-16 · 1 site observation
RECRUITING
PROspective Master-protocol for Evaluation of Systemic THErapeutics in Elderly With Thoracic MalignanciesNCT06646471 · 2024-09-26 · 1 site observation
RECRUITING
FIRST-NEC (GFPC 01-2022) - Combination of Durvalumab With Etoposide and PlatinumNCT06393816 · 2024-06-13 · 1 site observation
RECRUITING
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney FunctionNCT06307652 · 2024-04-12 · 1 site observation
RECRUITING
De-escalation Immunotherapy mAintenance Duration Trial for Stage IV Lung Cancer Patients With Disease Control After Chemo-immunotherapy InductionNCT05255302 · 2022-05-02 · 1 site observation
RECRUITING
Analysis of Biological Characteristics of Advanced ALK-rearranged NSCLCNCT05122806 · 2021-09-22 · 1 site observation
RECRUITING
Assessment of the Quality of Life of Multiple Sclerosis Patients Treated With Ofatumumab in Real-life in FranceNCT06157086 · 2023-12-21 · 1 site observation
ACTIVE_NOT_RECRUITING
Prospective Cohort of Locally Advanced and Metastatic Non-Small Cell Lung Cancer Patients With Activating EGFR MutationsNCT05103605 · 2021-05-12 · 1 site observation
ACTIVE_NOT_RECRUITING
The MiniMed™ 780G Glycemic Control and Quality of Life Study for the Treatment of Pediatric and Adult Subjects With Type 1 Diabetes in France.NCT04308291 · 2021-02-15 · 1 site observation
COMPLETED
PEmbRolizumab verSus chEmotherapy and pEmbrolizumab in Non-small-cell Lung Cancers (NSCLC) With PDL1 ≥ 50 %NCT04547504 · 2020-12-22 · 1 site observation
ACTIVE_NOT_RECRUITING
Observational Prospective Study of Quality of Life in Unresectable TNM Stage III NSCLC (OBSTINATE)NCT05049044 · 2020-12-18 · 1 site observation
ACTIVE_NOT_RECRUITING
Atezolizumab in Elderly Patients With Advanced Non-Small-Cell Lung Cancer and Receiving Carboplatin Paclitaxel ChemotherapyNCT03977194 · 2019-07-23 · 1 site observation
ACTIVE_NOT_RECRUITING
Denosumab and Nivolumab Combination As 2d-line Therapy in Stage IV NSC Lung Cancer with Bone Metastases (DENIVOS)NCT03669523 · 2018-11-06 · 1 site observation
COMPLETED
A Study to Provide Complementary Efficacy, Safety and Patient Reported Outcomes Data in Participants With Active Relapsing Forms of Multiple Sclerosis (MS) in a Pragmatic SettingNCT03589105 · 2018-08-06 · 1 site observation
COMPLETED
Nivolumab and Ipilimumab Versus Chimiotherapy in First Line Treatment in PS 2 or Elderly in Advanced NSCLC PatientsNCT03351361 · 2018-02-19 · 1 site observation
COMPLETED
Evaluation of PD-L1 (Programmed Death-Ligand 1) Tumor Expression in Patients With Large-cell Neuroendocrine Carcinoma (NEC)NCT03305133 · 2017-09-26 · 1 site observation
COMPLETED
Observational Study of Patients With Locally Advanced or Metastatic NSCLC (Non-Small Cell Lung Cancer)NCT03053297 · 2017-03-01 · 1 site observation
TERMINATED
Evaluation of the Impact of Nurse-led Telephone on Treatment ComplianceNCT02483416 · 2015-11-19 · 1 site observation
TERMINATED
Survival imProvement in Lung cancEr iNduced by DenOsUmab theRapyNCT02129699 · 2015-01-06 · 1 site observation
TERMINATED
Prospective Observational Study of Febrile Neutropenia (FN) and Pegfilgrastim Primary Prophylaxis in Breast Cancer and Non-Hodgkin's Lymphoma Patients Receiving High (>20%) FN-risk ChemotherapyNCT02178475 · 2014-07-18 · 1 site observation
COMPLETED
A Multicenter Randomized Phase III Study Comparing Second-line Treatment With Chemotherapy Associated or Not to Erlotinib in NSCLC Patients With Secondary Resistance to TKI-EGFRNCT02178397 · 2014-06-01 · 1 site observation
TERMINATED
Description of Clinical Anatomical Features and Long Term Follow-up for Patients With ALK RearrangementsNCT02727335 · 2014-05-01 · 1 site observation
COMPLETED
Retrospective Study in Non Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor (EGFR)NCT02293733 · 2014-01-01 · 1 site observation
COMPLETED
Therapeutic Strategies in Patients With Non-squamous Non-small Cell Lung Cancer With Brain MetastasesNCT02162537 · 2013-12-01 · 1 site observation
TERMINATED
Heart Failure Educational and Follow up PlatformNCT02110433 · 2013-12-01 · 1 site observation
COMPLETED
Evaluation of the DIABEO System in Poorly Controlled DM1 or DM2 Patients Treated With a Basal-bolus Insulin RegimenNCT02287532 · 2013-02-01 · 1 site observation
COMPLETED
Strategies for Maintenance Therapies in Advanced Non Small Cell Lung CancerNCT01631136 · 2012-07-01 · 1 site observation
COMPLETED
PEPITA Study: An Observational Study of Tarceva (Erlotinib) in Second Line in Patients With Locally Advanced or Metastatic Squamous Non-Small Cell Lung CancerNCT01659970 · 2012-06-01 · 1 site observation
COMPLETED
French National Observatory of the Patients With Non-small Cell Lung (NSCLC) and Molecular TestingsNCT01700582 · 2012-04-01 · 1 site observation
COMPLETED
Erlotinib and Docetaxel in Second Line of Treatment in Patients With Non Small Cell Lung CancerNCT01350817 · 2011-06-01 · 2 site observations
COMPLETED
An Observational Study of Glucocorticoid Use in Patients With Rheumatoid Arthritis on Treatment With RoActemra/Actemra (Tocilizumab)NCT01392001 · 2011-03-01 · 1 site observation
COMPLETED
Validation Study of RA-INF-Dx, a Multigene Molecular Test Used to Predict Non-Response to INfliximab TherapyNCT01299545 · 2011-02-01 · 1 site observation
TERMINATED
Observational Study on the Management of Patients With Non Small Cell Lung Cancer AdenocarcinomaNCT01167972 · 2010-09-01 · 1 site observation
COMPLETED
An Observational Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic or Recurrent Non-Squamous Non-Small Cell Lung CancerNCT01333007 · 2010-07-01 · 1 site observation
COMPLETED
An Observational Study of Tarceva (Erlotinib) in Patients With Non-Small Cell Lung CancerNCT01488331 · 2010-06-01 · 1 site observation
COMPLETED
Trial Involving Subjects Over 70 Years of Age With Non Small-cell Lung Cancer of Stage IV and Comparing a "Classical" Strategy of Treatment Allocation, With an"Optimized" Strategy Allocating the Same TreatmentsNCT01257139 · 2010-01-01 · 1 site observation
COMPLETED
Concomitant Radio-chemotherapy in the ElderlyNCT01029678 · 2010-01-01 · 1 site observation
COMPLETED
Bevacizumab in Extensive Small Cell Lung CancerNCT00930891 · 2009-09-01 · 1 site observation
COMPLETED
European Study of Cardiovascular RiskNCT00882336 · 2009-05-01 · 1 site observation
COMPLETED
Telmisartan 80mg+Hydrochlorothiazide (HCTZ) 25 mg in Hypertension: an Observational StudyNCT00909038 · 2009-05-01 · 1 site observation
COMPLETED
Evaluation of the Control Level of Asthmatic Patients With Seasonal Increase of Respiratory Symptoms (High and/or Low)NCT00882128 · 2009-05-01 · 1 site observation
COMPLETED
Epidemiological Study to Describe NSCLC Clinical Management Patterns in Europe. Lung-EPICLINNCT00831909 · 2009-01-01 · 1 site observation
COMPLETED
National Survey on HypertensionNCT00804167 · 2008-12-01 · 1 site observation
COMPLETED
The Second Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage TrialNCT00716079 · 2008-09-01 · 1 site observation
COMPLETED
National Survey on Coronary Patients and Heart Failure Performed in 2 Patient GroupsNCT00699959 · 2008-06-01 · 1 site observation
COMPLETED
National Survey on Hypertension in General Practitioner (GP) ConsultationNCT00695656 · 2008-04-01 · 1 site observation
COMPLETED
GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung CancerNCT00480025 · 2007-10-04 · 1 site observation
TERMINATED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.